Healthcare provider profile · identity verified

Alexander G. Berdy, MD

Internal Medicine · ANAHEIM, CA · NPI 1336216340

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	192
Amlodipine Besylate	Amlodipine Besylate	395	136
Levothyroxine Sodium	Levothyroxine Sodium	261	78
Omeprazole	Omeprazole	259	102
Lisinopril	Lisinopril	239	75
Simvastatin	Simvastatin	235	75
Terazosin Hcl	Terazosin Hcl	232	72
Tamsulosin Hcl	Tamsulosin Hcl	189	72
Losartan Potassium	Losartan Potassium	186	66
Rosuvastatin Calcium	Rosuvastatin Calcium	169	62
Meloxicam	Meloxicam	158	94
Atenolol	Atenolol	146	48
Metformin Hcl Er	Metformin Hcl	134	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	28
Alprazolam	Alprazolam	99	23
Finasteride	Finasteride	99	35
Metoprolol Tartrate	Metoprolol Tartrate	96	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	32
Albuterol Sulfate Hfa	Albuterol Sulfate	90	50
Alendronate Sodium	Alendronate Sodium	90	32
Metformin Hcl	Metformin Hcl	89	28
Pantoprazole Sodium	Pantoprazole Sodium	88	34
Glipizide	Glipizide	87	30
Eliquis	Apixaban	84	18
Trazodone Hcl	Trazodone Hcl	81	29
Azithromycin	Azithromycin	77	62
Temazepam	Temazepam	64	11
Fluoxetine Hcl	Fluoxetine Hcl	63	20
Gabapentin	Gabapentin	63	26
Potassium Chloride	Potassium Chloride	59	20
Pradaxa	Dabigatran Etexilate Mesylate	57	22
Triamcinolone Acetonide	Triamcinolone Acetonide	57	40
Furosemide	Furosemide	56	25
Tramadol Hcl	Tramadol Hcl	54	20
Carvedilol	Carvedilol	52	20
Allopurinol	Allopurinol	50	19
Hydrochlorothiazide	Hydrochlorothiazide	50	16
Bupropion Xl	Bupropion Hcl	49	23
Alvesco	Ciclesonide	46	29
Sertraline Hcl	Sertraline Hcl	45	16
Duloxetine Hcl	Duloxetine Hcl	42	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	15
Citalopram Hbr	Citalopram Hydrobromide	40	12
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	13
Propranolol Hcl	Propranolol Hcl	40	14
Trospium Chloride	Trospium Chloride	40	11
Ezetimibe	Ezetimibe	39	12
Hydrocortisone	Hydrocortisone	39	28
Clopidogrel	Clopidogrel Bisulfate	38	15
Ozempic	Semaglutide	38	suppressed
Estradiol	Estradiol	36	14
Humulin N	Insulin Nph Human Isophane	36	11
Valacyclovir	Valacyclovir Hcl	36	suppressed
Clonazepam	Clonazepam	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	31	31
Donepezil Hcl	Donepezil Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	12
Buspirone Hcl	Buspirone Hcl	29	12
Lorazepam	Lorazepam	29	suppressed
Nystatin	Nystatin	29	suppressed
Prednisone	Prednisone	29	23
Famotidine	Famotidine	28	14
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	28	28
Bisoprolol Fumarate	Bisoprolol Fumarate	27	13
Clobetasol Propionate	Clobetasol Propionate	27	11
Doxycycline Monohydrate	Doxycycline Monohydrate	27	23
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Cephalexin	Cephalexin	26	24
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Metoprolol Succinate	Metoprolol Succinate	24	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	23	23
Jardiance	Empagliflozin	23	suppressed
Ondansetron Odt	Ondansetron	23	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	22	suppressed
Naproxen	Naproxen	21	suppressed
Testosterone	Testosterone	21	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	12
Acyclovir	Acyclovir	19	suppressed
Amoxicillin	Amoxicillin	19	12
Digoxin	Digoxin	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	11
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Selenium Sulfide	Selenium Sulfide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Tacrolimus	Tacrolimus	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Lactulose	Lactulose	14	suppressed
Primidone	Primidone	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	12
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Nexletol	Bempedoic Acid	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error